Atreca, Inc. - (BCEL): Price and Financial Metrics

Atreca, Inc. - (BCEL): $0.08

0.00 (-1.81%)

POWR Rating

Component Grades

Momentum

F

Stability

D

Sentiment

Quality

C

Add BCEL to Watchlist
Sign Up

Industry: Biotech

Industry

F

Ranked

#124 of 390

in industry

BCEL Price/Volume Stats

Current price $0.08 52-week high $1.26
Prev. close $0.08 52-week low $0.05
Day low $0.08 Volume 200,737
Day high $0.08 Avg. volume 7,000,753
50-day MA $0.17 Dividend yield N/A
200-day MA $0.34 Market Cap 3.02M

BCEL Stock Price Chart Interactive Chart >


Atreca, Inc. - (BCEL) Company Bio


Atreca, Inc. is a biopharmaceutical company. It develops novel therapeutics and immunotherapies based on a deep understanding of the human immune response. Its technology leverages next-generation sequencing to identify the set of functional antibodies produced in patients during an immune response. The company was founded by Robert Axtell, Guy Cavet, Jeremy Sokolove, Tito A. Serafini, Paulette A. Dillon, Daniel Emerling, Wayne Volkmuth, Jonathan Woo, Yann Chong Tan, William H. Robinson and Lawrence J. Steinman in June 11, 2010 and is headquartered in Redwood, CA.


BCEL Latest News Stream


Event/Time News Detail
Loading, please wait...

BCEL Latest Social Stream


Loading social stream, please wait...

View Full BCEL Social Stream

Latest BCEL News From Around the Web

Below are the latest news stories about ATRECA INC that investors may wish to consider to help them evaluate BCEL as an investment opportunity.

Atreca Reports Third Quarter 2023 Financial Results and Announces Further Reorganization to Support Exploration of Strategic Alternatives

SAN CARLOS, Calif., Nov. 14, 2023 (GLOBE NEWSWIRE) -- Atreca, Inc. (Atreca) (NASDAQ: BCEL), a clinical-stage biotechnology company focused on developing novel therapeutics generated through a unique discovery platform based on interrogation of the active human immune response, today reported financial results for the third quarter ended September 30, 2023, and announced that the Company is implementing a further reduction in its workforce of approximately 40% while maintaining the necessary supp

Yahoo | November 14, 2023

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday

We're starting off the trading week right with a breakdown of the biggest pre-market stock movers worth noting on Monday morning!

William White on InvestorPlace | November 6, 2023

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday

It's time to dive into the biggest pre-market stock movers for Friday with all the shares investors will want to keep an eye on today!

William White on InvestorPlace | November 3, 2023

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday

We're starting off Thursday with a breakdown of the biggest pre-market stock movers traders need to know about this morning!

William White on InvestorPlace | October 19, 2023

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday

Pre-market stock movers are a hot topic worth checking out on Wednesday and we have all the latest news happening this morning!

William White on InvestorPlace | October 18, 2023

Read More 'BCEL' Stories Here

BCEL Price Returns

1-mo 10.96%
3-mo -73.33%
6-mo -70.48%
1-year -91.92%
3-year -99.30%
5-year N/A
YTD -39.39%
2023 -83.51%
2022 -73.58%
2021 -81.24%
2020 4.40%
2019 N/A

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!